Podcast appearances and mentions of howard gleckman

A live and interactive discussion with one of the leading voices in elder care policy that will provide insights into the complex world of aging services during this period of policy uncertainty. Howard Gleckman, a senior fellow at the Urban Institute and author of Caring for Our Parents will provide a comprehensive analysis drawing on his expertise in tax policy, elder care, and healthcare.https://howardgleckman.com/Caring for Our Parents: Inspiring Stories of Families Seeking New Solutions to America's Most Urgent Health Crisis Hardcover – May 26, 2009 by Howard Gleckman (Author)Summary Generated by https://notebooklm.google.com/ Gleckman began by addressing **Social Security**, highlighting President Trump's promise not to cut benefits directly. However, he cautioned that the administration's actions, such as limiting access through closed offices and phone line difficulties, are already impacting beneficiaries and applicants, particularly those seeking disability benefits, where waiting times are expected to exceed a year. More critically, Gleckman stressed the looming **insolvency of the Social Security trust fund within the next nine years**, which could lead to an automatic 23% cut in benefits if no action is taken. He criticized the political stalemate on this issue, noting that inaction is akin to "taking Social Security off a cliff".Turning to **Medicare**, Gleckman noted Trump's similar pledge not to cut benefits directly. However, he anticipated potential cuts to providers, which could further strain access to care. A significant focus was placed on **Medicare Advantage (MA)**, with the administration recently announcing a substantial 5.3% increase in payments to MA plans. Gleckman pointed out the inconsistency with the stated goal of cutting government spending. He discussed the possibility of MA becoming the default Medicare option, as suggested by Project 2025. While acknowledging potential benefits of coordinated care in theory, Gleckman raised concerns about network limitations, complexity, and prior authorizations in current MA plans. He also touched upon the negotiation of drug prices initiated by the Biden administration and the uncertainty of Trump's future stance on this, while noting the current administration's decision to not cover GLP-1 drugs for weight loss under Medicare and Medicaid.The **Older Americans Act (OAA)** and the **Administration for Community Living (ACL)** were also highlighted as being at risk. Gleckman predicted budget cuts for OAA programs like Meals on Wheels and adult day programs. More alarmingly, he discussed the announced plan to **abolish the ACL** and divide its functions among other HHS offices, along with the firing of half of its staff, including grant program administrators. This could severely disrupt the functioning of vital community-based services due to a lack of federal oversight and support. Gleckman also noted the potential impact of federal employee layoffs in the Washington D.C. area on the tax base and consequently on local senior service programs.Gleckman concluded by emphasizing the **unpredictability of the Trump administration** due to its impulsive and chaotic management style. He urged communities to proactively work together to support older adults and their caregivers during these uncertain times. He echoed the sentiment that individual storytelling and engagement with lawmakers are crucial for conveying the real-world impact of potential policy changes. The interactive nature of the discussion allowed participants to voice their concerns and ask questions, highlighting the community's eagerness to understand and navigate the evolving landscape of aging services.

What happens when critical aging services are put on the chopping block? The Administration for Community Living (ACL) is facing major restructuring, potentially dismantling key programs that support older adults and individuals with disabilities. In this episode, Howard Gleckman and Alison Bankoff explain why this decision matters—not just for seniors, but for families, caregivers, and communities nationwide. We'll break down the potential consequences, discuss how advocacy groups are responding, and highlight what you can do to ensure these vital services remain intact.

In these BONUS episodes of Daughterhood the Podcast, Daughterhood Founder Anne Tumlinson joins Rosanne to bring the caregiving conversation to a different level as we're joined by change leaders and policy experts. Today we speak with Howard Gleckman, senior fellow at the Urban Institute, where he is affiliated with the Tax Policy Center and the Retirement Policy Program. He speaks and writes frequently on aging and caregiving, as well as on tax policy. Howard is the author of Caring for Our Parents: Inspiring Stories of Families Seeking New Solutions to America's Most Urgent Health Care Crisis, as well as two blogs—TaxVox and Caring for Our Parents which you can find on Forbes.com. In 2016, I was a named one of the nation's top 50 Influencers in Aging by Next Avenue. Today, we discuss the recent changes in Washington regarding potential cuts to Medicaid, changes to Medicare, drug production, The Older Americans act, the ACA and much more. EPISODE TRANSCRIPT Daughterhood

Christine Benz, Morningstar's director of personal finance and retirement planning, interviews financial experts about different aspects of retirement in ‘How to Retire,' the companion podcast to her book of the same name. In this episode, Christine talks with author and researcher Howard Gleckman about long-term care.  How Long-Term Care Differs from Conventional HealthcareWhy Americans Need More Long-Term Care Than Ever BeforeLong-Term Care Isn't Just in Nursing HomesDoes Medicare Cover Long-Term Care Costs?Who Should Consider Long-Term Care Insurance?The Financial Implications of Continuing Care Retirement CommunitiesHoward Gleckman's Experience with Long-Term Care Key Takeaways Hi, I'm Christine Benz from Morningstar and welcome to the How to Retire podcast. It's a companion to my book, which is also called How to Retire. Each episode will provide a bite-sized lesson about how to do some aspect of retirement well.If you read my work regularly, you know that I'm a little bit obsessed with the topic of long-term care, not just how to pay for it, but also all of the other dimensions of it, like the impact on families. To help discuss that topic, I reached out to Howard Gleckman. He is the author of a book called Caring for Our Parents, and he is also a Senior Fellow at the Urban Institute, where he is affiliated with the Tax Policy Center and the Program on Retirement Policy. He also writes a great blog for Forbes. I asked him to discuss the basics of long-term care, as well as the financial ramifications and implications for caregivers. More from Howard GleckmanBioForbes ColumnUrban InstituteTaxVox blogCaring For Our Parents, by Howard GleckmanHoward Gleckman on The Long View: ‘We Pretend This Isn't a Problem' Read more from Christine Benz.How to Retire: Tips for Entering RetirementThe Hidden Crisis in Long-Term CareHow Likely Are You to Need Long-Term Care?6 Steps for Smart Long-Term-Care PlanningWorried About Long-Term Care Expenses? Let's Do Something About It. Watch more from How to Retire.How to Retire: Prioritize Tax Planning in RetirementHow to Retire: Transition from Saving to SpendingHow to Retire: Consider a Retirement Bucket Portfolio StrategyHow to Retire: Know What ‘Enough' Means in RetirementHow to Retire: Understand the Role of Working LongerHow to Retire: Stay Flexible with Your Retirement Spending  Read what our team is writing:Christine Benz Follow Christine Benz on social media.X: https://x.com/christine_benzLinkedIn: https://www.linkedin.com/in/christine-benz-b83b523

Tommy breaks down some tax numbers with Howard Gleckman, Senior Fellow in the Tax Policy Center

Our guest on the podcast today is Howard Gleckman. He is the author of a book called Caring for Our Parents and an expert on the topic of aging and caregiving. Howard is also a senior fellow at the Urban Institute where he is affiliated with the Tax Policy Center and the Program on Retirement Policy. He also writes a tax and budget policy blog called TaxVox, which is available at Forbes.com. Before joining the Urban Institute, he was a senior correspondent in the Washington Bureau of Businessweek.BackgroundBioUrban InstituteTaxVox blogCaring For Our Parents, by Howard GleckmanLong-Term Care and Cognitive Decline“Is Long-Term Care a Predictable Need, or an Unexpected One?” by Howard Gleckman, Forbes.com, April 15, 2022.“The U.S. Needs to Help Seniors and Their Families Navigate Long-Term Care,” by Howard Gleckman, Forbes.com, Oct. 11, 2022.“The Quiet Struggles With Those Living Alone With Memory Loss,” by Howard Gleckman, Forbes.com, July 18, 2023.“Which States Provide the Best—and Worst—Long-Term Care Services?” by Howard Gleckman, howardgleckman.com, Oct. 2, 2023.“Why Are Care Delivery Models for People With Dementia Developing so Slowly?” by Howard Gleckman, howardgleckman.com, June 27, 2023.“FDA Has Approved the Anti-Alzheimer's Drug, Leqembi. What You Need to Know,” by Howard Gleckman, howardgleckman.com, July 6, 2023.“Experts Raise Questions About the Safety of Anti-Alzheimer's Drug Leqembi,” by Howard Gleckman, howardgleckman.com, April 25, 2023.“Aging in Place Is all the Rage, But It's Not Easy,” by Howard Gleckman, Forbes.com, March 21, 2022.Cost of Care“Medicaid Will Pay for a Common Alzheimer's Test But It May Not Be Reliable,” by Howard Gleckman, howardgleckman.com, Jan. 9, 2024.“Why Medicare Is Right to Negotiate Drug Prices,” by Howard Gleckman, howardgleckman.com, Aug. 30, 2023.“The Biggest Barrier to New Anti-Alzheimer's Drugs May Be Cost, Not Medicare Rules,” by Howard Gleckman, howardgleckman.com, June 14, 2023.“The War Over Whether Medicare Should Pay for new Anti-Alzheimer's Drugs,” by Howard Gleckman, howardgleckman.com, May 17, 2023.“The U.S. Predicts Big Increases in Skilled Nursing and Long-Term Care Costs,” by Howard Gleckman, howardgleckman.com, April 14, 2023.“Should You Enroll in a Medicare Advantage Plan?” by Howard Gleckman, howardgleckman.com, Nov. 1, 2022.Government and Policy“CMS' New Transparency Rule Can Help ‘Weed Out a Few Bad Actors' but Won't Impact Deals Much, Other Factors at Play,” by Shelby Grebbin, skillednursingnews.com, Dec. 6, 2023.“Forbes' Gleckman: Biden's PE Ownership Scrutiny Is ‘Two Beats Behind,'” by Amy Stulick, skillednursingnews.com, April 28, 2022.“Who Really Owns Nursing Homes, and How the Feds Are About to Learn More,” by Howard Gleckman, howardgleckman.com, Nov. 27, 2023.“Should State Long-Term Care Insurance Funds Invest in Stocks?” by Howard Gleckman, howardgleckman.com, June 22, 2023.Caregivers“Forget National Caregivers Month. Think About What Family Caregivers Need,” by Howard Gleckman, howardgleckman.com, Nov. 7, 2023.“For the First Time, Traditional Medicare Will Pay to Support Family Caregivers,” by Howard Gleckman, howardgleckman.com, Aug. 23, 2023.OtherLotsa Helping HandsMedicare.govFive-Star Quality Rating System

In today's Bonus policy episode, Howard Gleckman joins Anne in discussing policy changes in 2023. Howard is a published author and writer whose professional expertise is founded on long-term care, health care, elder care, tax policy, budget policy and economics.   Howard was also a senior correspondent in the Washington bureau of Business Week. In our episode today, we discuss some of the major policy happenings in 2023 - the GUIDE program, CMS staffing standards, the decision to cover Leqembi and more. SHOW NOTES Howard Gleckman.com

There's a very good chance that your taxes are about to go up. That's because the Tax Cuts and Jobs Act of 2017, a massive overhaul of the tax code for both businesses and individual taxpayers that reduced taxes for many people, may expire if Congress doesn't act to extend it. In this episode of Edelman Financial Engines' Everyday Wealth™, Jean and wealth planner Isabel Barrow discuss ways to start planning for the possibility of higher taxes, including different strategies that could help reduce your tax burden. Then, Jean interviews Howard Gleckman, a senior fellow at the Urban Institute, about how the political climate will affect the outcome of the Tax Cuts and Jobs Act and what the fiscal ramifications could be. Next, Jennifer Chomicki, senior director of advanced planning strategies at Edelman Financial Engines, joins Jean and Isabel to discuss new tax technology that helps identify ways to potentially reduce your taxes.    Ms. Chatzky receives cash compensation for acting as host of the Everyday Wealth podcast and for related activities and therefore has an incentive to endorse Edelman Financial Engines and its planners. That compensation is a fixed sum paid on an annual basis; and reimbursement for certain expenses. The amount paid each year does not vary, is not based on show content or any results-dependent factors (e.g., popularity of the show). This show is prerecorded and any callers are prescreened. The views and opinions expressed by Howard Gleckman, a senior fellow in the Urban-Brookings Tax Policy Center at the Urban Institute, are solely his own and may not reflect the views or opinions of EFE or its planners. The information provided is for educational purposes only and should not be construed as investment or tax advice. Although some of the statistical and market information has been gathered from sources believed to be reliable, we do not guarantee its accuracy or completeness. You should consult with a financial advisor and tax professional to help determine the best options for your particular circumstances.See omnystudio.com/listener for privacy information.

What would a more perfect health care delivery system for older adults look like? Howard Gleckman, an Urban Institute Fellow, journalist and the author of Caring for Our Parents, will talk about where seniors now get care, who pays for it, how to plan for care an elder may need, and the importance of family communication Presented by Reston for a Lifetime in partnership with the Positive Aging Community. https://howardgleckman.com/

This week on Facing the Future, we hear from two experts on the federal budget process and the search for more revenue which mamy fiscal policy experts believe we are going to need - along with spending cuts - if we expect to truly address the historic imbalance between what the  government spends and what it takes in. Our guests are Howard Gleckman of the Urban Brookings Tax Policy Center, and Tom Kahn, Faculty Fellow at the Center for Congressional and Presidential Studies at American University who for 20 years was staff director for Democrats on the House Budget Committee

This week on Facing the Future, we hear from two experts on the federal budget process and the search for more revenue which mamy fiscal policy experts believe we are going to need - along with spending cutd - if we expect to truly address the historic imbalance between what the government spends and what it takes in. Our guests are Howard Gleckman of the Urban Brookings Tax Policy Center, and Tom Kahn, Faculty Fellow at the Center for Congressional and Presidential Studies at American University who for 20 years was staff director for Democrats on the House Budget Committee.

Here at Daughterhood, we receive numerous questions regarding governmental policy, and the myriad of ways it affects the healthcare system and each of us both as patient and as caregiver.  It was my pleasure to speak with two experts in the field and friends of the podcast - Howard Gleckman Senior Fellow at The Urban Institute as well as a columnist at Forbes, editor of TaxVox Blog for the Tax Policy Center and author of Caring for our parents. And creator of Daughterhood Anne Tumlinson who is also the Founder and CEO of ATI Advisory a national research and consulting firm that shapes public policy and business strategy to reform care delivery for individuals with complex care needs and their families.  We discuss many issues like the challenges of trying to change policy, the importance of lawmakers hearing and understanding the challenges caregivers face, how policy shapes the care we receive and the importance of making our voices heard.  Daughterhood.org HowardGleckman.com

Here at Daughterhood, we receive numerous questions regarding governmental policy, and the myriad of ways it affects the healthcare system and each of us both as patient and as caregiver.  It was my pleasure to speak with two experts in the field and friends of the podcast - Howard Gleckman Senior Fellow at The Urban Institute as well as a columnist at Forbes, editor of TaxVox Blog for the Tax Policy Center and author of Caring for our parents.  And creator of Daughterhood Anne Tumlinson who is also the Founder and CEO of ATI Advisory a national research and consulting firm that shapes public policy and business strategy to reform care delivery for individuals with complex care needs and their families.  We discuss many issues like the challenges of trying to change policy, the importance of lawmakers hearing and understanding the challenges caregivers face, how policy shapes the care we receive and the importance of making our voices heard.  Daughterhood.org HowardGleckman.com

Howard and I have an essential discussion about aging in America. We talk about the lack of a long term care system in the United States as opposed to other countries, aging at home vs. senior living facilities, and how to know when we should be talking to our parents and deciding for ourselves when it's time to consider alternate housing and how to accomplish the change. Caring for our Parents - the Book https://howardgleckman.com/ https://twitter.com/howard_gleckman hgleckman@urban.org

Howard Gleckman joins Tommy to talk about the inflation reduction act and what it will mean for taxpayers. 

An aging population colliding with a severe workforce shortage is creating a crisis for the home care industry. In this Newsmakers Podcast, Howard Gleckman, senior fellow at the Brookings-Urban Tax Policy Center, talks to McKnight's Home Care Daily Pulse about what the industry and policymakers need to do to address the crisis.

It was 1996 when journalist Howard Gleckman got "the call" — about emergency care for his mother-in-law. Soon he was managing care for three older family members, and found the system impenetrable. He's since made a career of explaining how long-term care works in the U.S., and how Wall Street investors are helping decide the kind of care your grandmother gets.

Howard Gleckman is a senior fellow at the Urban Institute, where he is affiliated with the Tax Policy Center and the retirement Policy Program. In 2016, Next Avenue named Howard, one of the nation's top 50 influencers in aging. Howard and I spoke about the policies surrounding the caregiving crisis, how we got here, and his hope for going forward.

Gasoline prices have reached record highs in recent weeks, spurring lawmakers across the country to look for ways to offer some relief. A popular target: the excise taxes the federal government and states collect to fund transportation programs. Some congressional Democrats have floated a suspension of the 18.3 cent-per-gallon federal gas tax, while many governors are pursuing state holidays that could provide some temporarily relief to drivers. Temporarily ditching the gas tax would offer some obvious political benefits for lawmakers running for re-election this year. But how much would it actually help consumers with the national average for regular gasoline up to well over $4 a gallon and gas prices nearing $6 a gallon in California? Lucy Dadayan and Howard Gleckman of the Urban-Brookings Tax Policy Center appear on the latest episode of our weekly Talking Tax podcast to talk about proposed gas tax holidays. Gleckman argues that suspending the federal excise tax could actually fuel further price increases, while Dadayan suggests states should instead look at targeted tax rebates to help low-income families struggling with inflation. Do you have feedback on this episode of Talking Tax? Give us a call and leave a voicemail at 703-341-3690.

Howard Gleckman is a senior fellow at the Urban Institute, where he is affiliated with the Tax Policy Center and the retirement Policy Program. In 2016, Next Avenue named Howard, one of the nation's top 50 influencers in aging. Howard and I spoke about the policies surrounding the caregiving crisis, how we got here, and his hope for going forward.

New Drug for Alzheimer's Disease "Don't let yourself be sucked in by all of the publicity and marketing about the new drug for Alzheimer's. Think about whether it's got any benefit, the side effects— which can be very severe, and think about where that money otherwise would go." Howard Gleckman, Senior Fellow, Consultant, and Editor, TaxVox Blog ________________________________________________ Aducanumab (brand name AduhelmTM) received expedited approval from the Food and Drug Administration (FDA) on June 7, 2021, making it the first Alzheimer's disease drug approved after 18 years.    Since then, the FDA has changed the approval's original wording to suggest that it be used exclusively in select individuals with moderate cognitive decline or early Alzheimer's disease.   Further research is now being done because of the FDA's recent approval of Aduhelm, which sparked worries about its safety, efficacy, and cost.    In today's episode of This Is Getting Old: Moving Towards An Age-Friendly World, we will be talking about The New Drug for Alzheimer's Disease known as Aducanumab (marketed as AduhelmTM). Today, I am joined by Howard Gleckman, a Senior Fellow with the Urban Institute, who will shed some light on the newest drug available for Alzheimer's disease. Part One Of 'New Drug for Alzheimer's Disease' Understanding Alzheimer's Disease In A Nutshell Alzheimer's disease is only one form of dementia; there are many other types, including Vascular disease, Lewy Body disease, Frontotemporal Degeneration (FTD), Parkinson's, and mixed pathologies. Alzheimer's disease is the most common form – 60-80% of all cases of dementia, but many people do have mixed pathologies, meaning they have more than one form of the disease. This is complicated because confirming what type or types of dementia a person has can only be done by autopsy (I've done a previous podcast on how Alzheimer's disease is diagnosed if you would like to learn more).    You can also learn more about Alzheimer's Facts and Figures (2021), an annual report published by the Alzheimer's Association, to learn more about the different types of dementia and associated characteristics (pages 6 and 7 of the 2021 report).  Signs And Symptoms Of Alzheimer's Disease Early symptoms of Alzheimer's disease are trouble with your memory – remembering recent conversations, names, or events – or being depressed or apathetic, which means having a general lack of interest or enthusiasm about things you were formerly excited about.   As the disease progresses and moves into the moderate and advanced stages, symptoms include difficulty communicating with words, being disoriented, confused, having poor judgment, behavioral changes, and ultimately, in the end stages, difficulty speaking, walking, and swallowing.  "Not all people with MCI transition into Alzheimer's disease. We don't know or understand the mechanism of why that happens, why some people transition, or some people don't. So then you could be potentially giving a drug to a group of people that would have never progressed to Alzheimer's disease."  Melissa Batchelor, PhD, RN, FNP-BC, FGSA, FAAN The Brain Changes From A Grape To A Raisin With Alzheimer's In Alzheimer's disease, the brain shrinks – can be seen on a head CT; and two proteins called beta-amyloid and tau develop and somehow become toxic to the brain. The beta-amyloid clumps into plaques, which slowly build up between neurons, and abnormal tau accumulate, eventually forming tangles inside the neurons. As the level of amyloid reaches a tipping point, there is a rapid spread of tau throughout the brain. These plaques and tangles cause the neurons to lose their ability to communicate. The NIH has a great 4-minute video that shows you this process visually. Drugs For Alzheimer's: What's On The Horizon? Acetylcholine is a neurotransmitter that also plays an essential role in cognitive function related to memory and paying attention.  Acetylcholinesterase is an enzyme that breaks down acetylcholine – so cholinesterase inhibitors are oral medications that prevent the breakdown of acetylcholine.   Right now, we have at least 3 Acetylcholinesterase inhibitors drugs approved by the FDA that work for a certain period but don't modify the disease course.   Scientists are working on new treatments for Alzheimer's that include  anti-amyloid therapy, anti neuroinflammation therapy, Anti-Tau therapy, Neuroprotection, cognitive enhancers, and medications that relieve the behavioral and psychological symptoms often seen in dementia.   Part Two Of 'New Drug for Alzheimer's Disease' Aducanumab (Brand Name AduhelmTM) The Newly Approved Alzheimer's Drug. Should You Take It? How Aducanumab (AduhelmTM) Works (Or Suppose To Work)? Aducanumab (Aduhelm) is a monoclonal antibody developed in a facility to bind to the amyloid molecule that causes plaques in Alzheimer's patient's brains. According to most experts, the plaques develop first and harm brain cells, prompting tau tangles to grow within them, eventually killing the cells.  When Aducanumab binds to the plaque, the body's immune system attacks it, mistaking it for a foreign intruder and removing it. The goal is that after the plaques are eliminated, the brain cells would stop dying, and thought, cognition, function, memory, and behavior will improve. How Aducanumab (AduhelmTM) Is Administered? The newly approved Aducanumab (AduhelmTM) is a Medicare part B drug. Most of us are familiar with the Part D drugs, which are the pills that we buy in the pharmacy. Part B drugs, on the other hand, are injectables or infusion drugs. That means you generally get this drug at a physician's clinic, an infusion center, or a hospital. Simply put, to take the drug, you need an intravenous infusion every four weeks — forever. Who Qualifies For Aducanumab (AduhelmTM)? Physicians may prescribe the medication for treatment in people with early-stage Alzheimer's disease based on the clinical studies that were conducted.  Early-stage Alzheimer's disease patients refer to people with Alzheimer's disease in the early stages of the disease, such as moderate cognitive impairment or mild dementia. People living with early stage Alzheimer's disease may be able to operate normally, or they may need assistance with more complex tasks such as bill payments, grocery shopping, cooking, or managing their checkbook. Those who need help with bathing, grooming, or other basic tasks are not in the early stages of the disease, and the medication is not recommended for them.   However, it's best to note that Alzheimer's disease does not affect anyone with moderate cognitive impairment or mild dementia. There are a variety of additional factors that contribute to these issues. Alzheimer's can only be diagnosed by an amyloid PET scan or lumbar puncture, both of which confirm the presence of Alzheimer's amyloid plaques. Most insurance plans now cover a lumbar puncture; however, an amyloid PET scan (which costs about $5,000) is not. Furthermore, what makes Alzheimer's disease different from other chronic conditions is the blood-brain barrier. How do you get the drug through that blood-brain barrier that's meant to protect the brain? "FDA's decision is giving people false hope. It's making them believe that if they scrape together somehow all of this money, there's going to be this magic cure for this disease, and we don't have the evidence that that's true."    Howard Gleckman, Senior Fellow, Consultant, and Editor, TaxVox How Much Does Aducanumab (Aduhelm) Cost? Howard Gleckman explained that Aducanumab is estimated to cost $56,000 per year by Biogen, the company that manufactures it. It is unknown if this medicine will be covered by Medicaid, Medicare, or private insurance. Biogen said they're working on a deal with the Veterans Health Administration (VA) to pay for this drug for veterans receiving VA treatment. However, VA said they would not include it in their formulary, and private insurance companies are all over the place.    Similarly, the Center for Medicare and Medicaid Services (CMS) is still not sure if they will cover the drug. And if they do, AduhelmTM would be covered by Medicare Part B (because it's an infusion) rather than Medicare Part D (prescription drug coverage). And even if they do decide to cover the medication, Medicare only pays 80% of Part B costs and 20% is out-of-pocket for consumers. Annual out-of-pocket costs would be over $11,000 -these costs  make the drug out of reach for many Americans. Howard asks that when considering the cost being $56 000 a year per person, what will it cost Medicare annually? When the drug has not been found to be effective,  we could be investing in the Home and Community-Based Services (HCBS) that we have evidence do work. The bottom line is that geriatricians and healthcare providers are left to explain to patients why they are not eligible to take this medication, and why  it's considered a "scam" by scientists and healthcare professionals alike. But, Does Aducanumab (AduhelmTM) Work? Briefly stated, there were two major clinical studies to determine the drug's efficacy, side effects, and overall safety. One of the trials returned positive, indicating that the medication helped to halt the loss in cognition, memory, and functioning that is so common in Alzheimer's disease.    The results of the other extensive research were negative. The findings indicate that there's no evidence to prove whether the drug is working or not.   Another element to decide is that the perceived upside — if the medication performs as much as it did in the successful trial — is next to nothing.    The Role Played By The Food and Drug Administration (FDA) The FDA was established in 1906 to protect consumers from unsafe medications and unsafe substances that falsely claimed efficacy for some treatment without proof.  Long-standing FDA Approval Process for all drugs built on how clinical trials are conducted to move medication from the laboratory into use by human beings. With that, FDA approval can take 12-15 years at an average cost of $2.6 billion to a manufacturer. Biogen spent about 18 billion dollars to develop this drug.    Moreover, in 14 clinical trials, after significantly reducing beta-amyloid, this drug did not result in a significant change in Mini-Mental State Examination scores. In other words, there has been no convincing clinical evidence that clearing beta-amyloid from the brain results in any benefit to the patient. The FDA ignored the recommendation of an Independent Data Monitoring Committee that found zero evidence that this drug slowed down AD progression; in fact, patients given Aducanumab in the trials did worse than patients who received the placebo.  The Independent Data Monitoring Committee recommended that the Phase III trial of Aducanumab be terminated.   These actions made by the FDA in ignoring the recommendations of the Expert Alzheimer's Disease Panel and approving the drug for use caused three members to quit and raised several controversies.  About Howard Gleckman, Senior Fellow, Consultant and Editor, TaxVox Blog Howard Gleckman is a senior fellow in the Urban-Brookings Tax Policy Center at the Urban Institute. He is also affiliated with Urban's Program on Retirement Policy and is the author of the book Caring for Our Parents. He also writes two regular columns for Forbes.com, on tax policy and eldercare.   Connect with Howard by checking out his Personal Blog   About Melissa Batchelor, PhD, RN, FNP-BC, FGSA, FAAN:   I earned my Bachelor of Science in Nursing ('96) and Master of Science in Nursing ('00) as a Family Nurse Practitioner (FNP) from the University of North Carolina Wilmington (UNCW) School of Nursing (SON). I genuinely enjoy working with the complex medical needs of older adults. I worked full-time for five years as an FNP in geriatric primary care across many long-term care settings (skilled nursing homes, assisted living, home, and office visits), then transitioned into academic nursing in 2005, joining the faculty at UNCW SON lecturer. I obtained my Ph.D. in Nursing and a post-master's Certificate in Nursing Education from the Medical University of South Carolina College of Nursing ('11). I then joined the faculty at Duke University School of Nursing as an Assistant Professor. My family moved to northern Virginia in 2015 and led to me joining the George Washington University (GW) School of Nursing faculty in 2018 as a (tenured) Associate Professor. I am also the Director of the GW Center for Aging, Health, and Humanities. Please find out more about her work at https://melissabphd.com/.  

Most baby boomers who retire today can expect to live years longer than their parents or any previous generation. That's the good news. But there's a greatly increased need for long-term care as they age. The current system is in crisis and needs much more than a facelift. In this episode, we hear first from a policy expert, Howard Gleckman, of the Tax Policy Institute, who explains why solutions to this crisis have been so hard to find. We also interview Stuart Butler and Paul Van de Water on their differences over paying for long-term care, and how they found common ground.  This podcast was produced with the help of Convergence Center for Policy Resolution. Convergence recently published Rethinking Care for Older Adults, a report with recommendations to improve care, housing, and services for seniors.

Rod Arquette Show Daily Rundown – Monday, June 21, 20214:20 pm: William Jacobson, a Professor at Cornell Law School and founder of the blog Legal Insurrection joins the show to discuss how the media is panicking at mounting opposition to Critical Race Theory4:38 pm: Representative Rex Shipp joins Rod to discuss his plans to once again run legislation in 2022 that restricts gender affirming healthcare for transgender youth in the state5:05 pm: Local attorney and Deseret News contributor Michael Erickson joins the program to discuss his recent piece about how the new Juneteenth holiday is mean for everyone, not just Black Americans6:05 pm: Representative Joel Ferry joins the program to discuss just how dire the drought conditions are becoming in Utah6:20 pm: Adam Andrzejewski, CEO and Founder of OpenTheBooks.com joins Rod to discuss how the new Juneteenth federal holiday means yet another paid day off for federal employees6:35 pm: Howard Gleckman, Senior Fellow at the Tax Policy Center at the Brookings Institution joins the program to discuss how 60% of American tax payers face a tax increase under Joe Biden's proposals

Anne Tumlinson, founder of Daughterhood.orgCovid-19 had taken the lives of 181,000 people in nursing homes, assisted living and other long-term care facilities ….. one-third of the national total. The troubles have intensified a spotlight on long-running questions about how communities can do a better job supporting people who need care but want to live outside an institutional setting.I explore these questions in a new New York Times Retiring column posted this weekend. I interviewed a couple dozen experts for the story in areas ranging from health care to housing, urban planning and health care. I’m planning a series of podcast follow-ups to dive deeper into different aspects of the story. My podcast guest this week is one of those experts. Anne Tumlinson is one of the nation’s top authorities in public policy on caregiving, having worked for years on Capitol Hill and in the private sector as an analyst, researcher and consultant. She is the founder of ATI Advisory, a Washington, D.C.-based research and advisory services firm that works to reform health and long-term care delivery and financing for the nation’s frail and vulnerable older adults. Daughterhood.orgBut she also is the founder of Daughterhood.org, a fascinating national network of support circles for caregivers. Earlier in her career, Anne worked as a healthcare advisor to the late Congressman John Lewis (D-GA), and then as the lead for Medicaid program oversight at the Office of Management and Budget. I asked Anne for her thoughts on the challenges people face when they need to make caregiving decisions for loved ones, most often on short timelines and without adequate preparation or knowledge — and, how that affects the choices that need to be made between institutional and home-based care.Listen to the podcast by clicking the player icon at the top of the newsletter. The podcast also can be found on Apple Podcasts, Spotify and Stitcher.Biden’s big bet on expansion of home-based careMy New York Times column notes that the recently-approved American Rescue Act contains a very large ($12.7 billion) increase in federal spending on home and community-based services through the Medicaid program. Moreover, the $2 trillion infrastructure plan proposed by the Administration this week includes an addition $400 billion over eight years to bolster long-term care outside of institutional settings.Howard Gleckman notes in a Forbes.com post that this latest proposal is an important step forward - but that it does nott address the nation’s broader long-term care problems:It focuses on only one piece the puzzle—Medicaid HCBS. And it still won’t provide sufficient services for many older adults and younger people with disabilities who rely on Medicaid for their care. It doesn’t boost funding for a long list of non-Medicaid federal programs that are critical to those living at home. And it does nothing at all for middle-income Americans who are unable to pay for long-term care insurance but are not poor enough to qualify for Medicaid. The rest of the Washington agenda on retirementCongress recently rescued the retirements of more than 1 million workers who faced the prospect that the pensions they earned and had been promised might evaporate. The American Rescue Act allocated $86 billion for grants to struggling multiemployer pension funds that would allow them to continue paying full benefits. The law authorizes the Pension Benefit Guaranty Corporation (PBGC) to make the grants, which do not need to be repaid.The generosity of the move came as a surprise. Previously, Democrats had been pushing a package of low-interest loans to aid the multiemployer funds, while Republicans wanted to boost insurance premiums paid by employers, add new premiums paid by plan participants, and force more conservative accounting assumptions. But the Democratic majority is looking at things a bit differently this year. And so long as Congress is casting a benign eye on the well-being of these pensioners, I have a short list of other “must-do” retirement items for the consideration of lawmakers. And these are reforms that will impact a much larger - and more demographically diverse - group of retirees now and in the years ahead than the multiemployer plan fix.My list includes:Expansion of Social SecurityReduction of the Medicare eligibility ageFixing long-term care insuranceBuilding affordable senior housingLearn more in my Reuters column this week.Subscribe to the newsletterYou’re subscribed to occasional, short posts sent to my free list. Sign up for the paid edition to receive my weekly in-depth report, plus online access to my series of retirement guides. This is a public episode. Get access to private episodes at retirementrevised.substack.com/subscribe

The pandemic has amplified the flaws of the nation’s long-term care system just as a new Administration takes power in Washington, DC. Urban Institute senior fellow Howard Gleckman will describe the key aging policy challenges facing the Biden Administration and discuss the reforms the White House may propose. Howard Gleckman is a senior fellow at the Urban Institute, where he is affiliated with the Tax Policy Center and the Program on Retirement Policy. He is the author of Caring for Our Parents (St. Martin’s Press) and writes a weekly column on aging issues for Forbes.com. In 2016, Mr. Gleckman was named one of the nation’s top 50 Influencers in Aging by Next Avenue Mr. Gleckman is president of the Jewish Council for the Aging of Greater Washington and serves on the National Capital regional governing board for Johns Hopkins Medicine. He previously served as chair of the Board of Trustees of Suburban Hospital (Bethesda, MD)

Many Catholic nursing homes and long-term care facilities are closing, being sold, or being reconfigured in an effort to keep them viable. Howard Gleckman, senior fellow at The Urban Institute, and Susan McDonough, the Catholic Eldercare and Acute Care specialist for Ziegler Investment Banking, discuss the various challenges these facilities face and how to pursue policy changes that improve the care our elders need.Health Progress Winter 2021 Issue - "Aging and Long-Term Care"

A discussion with Howard Gleckman, senior fellow in the Urban-Brookings Tax Policy Center at the Urban Institute, on how the Biden administration will impact you and your taxes.

In this recap of this week’s episode with Howard Gleckman, Mary and I have a bit to say about that. In particular, we discuss his impressive knowledge of tax policy, funding, and long-term care and his ability to bring all those things together in a succinct and easily understandable way. We examine his views on a broken long-term care system, issues around staffing, and the challenges faced by family caregivers. What resonates with us, of course, is Gleckman’s call to action around what nursing homes need to do to survive in a post-COVID era: break the mold and be willing to try something truly different from the old ways of doing things. Find Gleckman’s articles in Forbes here: https://www.forbes.com/sites/howardgleckman/#6e3afe4c7417

In this episode, Susan Ryan talks with Howard Gleckman, a senior fellow at The Urban Institute in Washington, D.C., where he is affiliated with both the Tax Policy Center and the Program on Retirement Policy. Gleckman is the author of Caring for our Parents, a book that tells the stories of the families who struggle every day with the care needs of their loved ones. Susan and Howard discuss the COVID-19 crisis and his assessment of the profound challenges and systemic flaws that have been exposed. In addition, Howard discusses the workforce issues, funding, lack of affordable and accessible options that address critical health disparities, and much more. Howard’s astute insights, experiences, and expertise are thought provoking and those that hopefully will spur you to take action. Get Howard Gleckman’s book here: https://howardgleckman.com/books/caring-for-our-parents/

Chase is joined on the show by Howard Gleckman, senior fellow at the Urban-Brookings Tax Policy Center at the Urban Institute, Andrew Biggs, a resident scholar at the American Enterprise Institute, Concord Coalition Executive Director, Bob Bixby, and Concord's Policy Director, Tori Gorman. They discuss COVID-19 relief legislation, President Trump’s executive actions concerning payroll taxes, their potential implications and Social Security.

Chase is joined on the show by Howard Gleckman, senior fellow at the Urban-Brookings Tax Policy Center at the Urban Institute, Andrew Biggs, a resident scholar at the American Enterprise Institute, Concord Coalition Executive Director Bob Bixby and Concord's Policy Director Tori Gorman. They discuss COVID-19 relief legislation, President Trump’s executive actions concerning payroll taxes, their potential implications and Social Security.

Howard Gleckman joins Tommy to talk about if businesses need another stimulus check.

This week on the program, we’re going to attempt to untangle the annuities market. They come in an almost unbelievably complicated array of flavors and types, and their contracts can be very difficult to understand.But before we get to that, I wanted to share a few thoughts with you about the coronavirus.The pandemic puts everyone at risk, but older people are the most vulnerable. As a journalist covering aging, I’m mindful of that, of course. And, I’m starting to carefully reorient my coverage to do the best I can to provide useful information to readers of my stories, and people who listen to the podcast. I’m looking at this as a health story of course, but also a financial security story due to the massive impact of the crisis on the markets and most likely, the economy. The virus is starting to reshape conditions here in the U.S. and around the world that we’re barely starting to understand. One thing I know I can do is pass along useful, authoritative information. As a journalist, I sift through hundreds of news articles, research reports, podcasts and video interviews every week. I plan to pass along the most credible, authoritative information I can find every week in the newsletter - both the subscriber and free editions. This week, scroll down a bit and you’ll find a post with links to advice for older adults from the CDC, and an interview with Dr. Anthony Fauci of NIH on the podcast of the Journal of the American Medical Association — also, an article about how the virus is impacting nursing homes.You can also look for an article from my in this Sunday’s New York Times business section about how retirement investors can cope with their worst instincts during the current market meltdown. I’ll have a link to that story in next week’s newsletter. So, back to annuities. Most people think of them as a way to provide guaranteed lifetime income in retirement - and you certainly can achieve that goal. But others really are more like investment products with optional income conversion features. Annuity sales have been rising. Some of that is driven by the country’s demographics - as baby boomers reach retirement age, buyers are attracted by protection from the volatility of stocks. That last point seems especially salient considering the way the stock market has been nose-diving over the last couple weeks.I don’t think annuities are right for everyone. Not even close to everyone. But they make sense in some situations, so this week I invited one of the most knowledgeable observers of the annuity marke that I know to join me on the podcast - Kerry Pechter. Kerry is editor and publisher of the Retirement Income Journal, which covers the industry. He also is author of Annuities for Dummies. Like most books in the well-known Dummies series, Kerry’s book provides easy-to-grasp explanations of the various annuity types and how they work. So, if you are thinking about an annuity, get Kerry’s book.But first, give a listen to my interview with Kerry Pechter.Roundup of news and information on COVID-19 The risk of contracting the coronavirus and becoming ill with COVID-19 is highest for older Americans. I’ll be curating and passing along the best information I can find each week to readers of the newsletter during this crisis.Here’s a short video overview from the Centers for Disease Control on what older adults need to know. And here’s an interview on the spread of the virus with Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, conducted by Dr. Howard Bauchner, editor of the Journal of the American Medical Association.Nursing homes: With the deaths of 18 residents in a nursing home in Washington state, industry leaders recommended strict limits this week on visits at facilities across the country, according to the The New York Times: Thousands of nursing homes and assisted-living centers across the United States are becoming islands of isolation as health care administrators take unprecedented steps to lock them down, hoping to protect some of the nation’s most vulnerable residents from the threat posed by the coronavirus.On Tuesday, industry leaders recommended curtailing all but essential visits at homes across the country, calling the challenge posed by the novel coronavirus “one of the most significant, if not the most significant” issues the industry has ever faced. Five long-term care facilities in Washington State have been hit, but officials worry the virus could already have spread to far more facilities with still-undetected cases.“The mortality rate is shocking,” said Mark Parkinson, president and chief executive of the American Health Care Association. He said the death rate might well exceed the 15 percent that had been reported in China for people aged 80 and older.What should you do if you or a family member are living in a nursing home or assisted living facility, or may need to go to a skilled nursing facility after a hospital stay? Howard Gleckman, an expert on long-term care, offers these thoughts in a post for Forbes.com:There is a lot to think about, but experts have two main pieces of advice:Don’t panic. The risk of contracting COVID-19 remains very low.Make sure the facilities are practicing good infection control—something they should be doing all the time, regardless of the immediate news.No doubt, residents of care facilities are at high risk for severe illness or even death if they contract COVID-19, the disease caused by the novel coronavirus. And the multiple deaths at a Kirkland, WA nursing home only raised those concerns.To learn if a specific facility is doing it right, you can ask a few basic questions. The Centers for Disease Control has a simple factsheet for consumers called the “Top 10 Infection Prevention Questions to Ask a Nursing Home’s Leaders.”New guide: How to time your retirementIf you’re a paid subscriber to the newsletter, you know I’ve been publishing a series of guides on key retirement topics. The latest is a guide on timing retirement decisions. This can be a really important inflection point for your financial success in retirement, so it’s worth thinking about carefully.The last years of work usually are peak earning years. And working even a few years more years - or less - will impact your retirement math significantly. Your timing affects the number of years that you’ll rely on savings to meet living expenses. It impacts the number of years that you can contribute to retirement saving accounts. And perhaps most important, working longer helps sets the stage for a delayed Social Security claim. That’s because it provides the income you need to meet living expenses while you wait to file.But setting a retirement target date and sticking to it can be very difficult . . . even risky.About one-third of workers tell pollsters they plan to work well past traditional retirement age, or not retire at all. But the data also tell us that about one-third of workers retire earlier than expected - and that the farther out you push your target date, the less likely you are to work to that date.The most common causes for unexpected early retirement are health problems and job loss. But the study uncovered clear reasons for unplanned early retirement only in about one-quarter of cases.Other reasons are more difficult to measure. The pull of leisure activities and time with family are factors, along with possible age discrimination. But the quality of work also matters.The guides are downloadable, quick reads, each paired with a podcast interview on the subject at hand. My aim is to create a series of just-in-time retirement education modules - read the guide, listen to the podcast and you’re good to go. The series already includes guides on claiming Social Security, transitioning to Medicare and how to hire a financial planner. Becoming a subscriber is easy - to sign up, click the little green button at the bottom of the newsletter page, or visit my website to learn more. The subscription price is just $5 month, and you can cancel easily at any time if you’re not happy. Once you subscribe, you’ll have access to the entire retirement guide series, including this new one on retirement timing. Plus, you’ll get links to all the articles I publish for Reuters, The New York Times, Morningstar and Wealthmanagement.com. I also publish links to the most interesting new research in the field, and links to work by other journalists that I find compelling. Finally, you’ll be supporting independent, unbiased journalism. Thanks for listening - and I hope to see you over on the subscriber side soon. This is a public episode. Get access to private episodes at retirementrevised.substack.com/subscribe

Dr. K talks with Howard Gleckman, a family caregiving and long-term care insurance expert. They discuss long-term care insurance, family caregiving, the struggles many older adults and families face in paying for late-life care, and much more. They also discuss Washington State s new public long-term care plan and other developments that might make services available to more people. The post 096 Interview: Paying for Long-Term Care: 2019 Updates appeared first on Better Health While Aging.

Taxes are due on April 15 and Americans are finding out how the 2017 law affected them. Howard Gleckman, a senior fellow at the Tax Policy Center, a nonpartisan think tank, and Peter Cohn, CQ's tax editor, discuss how the law has played out for both individuals and corporations and find that it's given some a windfall, and rationalized the code for others, but hasn't done as much as Republicans expected to juice economic growth. Learn more about your ad choices. Visit megaphone.fm/adchoices

https://youtu.be/iIYKQz3C4q4 Please join our host Laurie Scherrer as she has a very informational conversation about "Medicare" with Howard Gleckman. Howard is a Senior Fellow at the Urban and Brookings Institute, author of the book “Caring for our Parents”, a columnist for Forbes.com, and serves on numerous boards.

Dr. K talks with Howard Gleckman, a family caregiving and long-term care insurance expert. They discuss long-term care insurance, family caregiving, the struggles many older adults and families face in paying for late-life care, and much more. The post 059 Interview: Long-Term Care Insurance & Financing Late-Life Care Needs appeared first on Better Health While Aging.

Francine Lacqua sits down for a conversation with U.S. Commerce Secretary Wilbur Ross following reports of Russia linked investments. Then, Michael McKee discusses NY Fed President William Dudley's recent retirement announcement. Prior to that, Jonathan Golub, Credit Suisse Securities' chief U.S. equity strategist, says the markets are perceiving Jay Powell as a continued Janet Yellen governance. Howard Gleckman, a senior fellow at the Tax Policy Center, says the Republican tax bill's proposed 20 percent corporate tax rate won't survive. Finally, Mohammed Alyahya, a nonresident fellow at the Rafik Hariri Center for the Middle East, says the issue of a Saudi corruption 'Band-Aid' is being torn off but perhaps may lead to uncertainty.  Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Francine Lacqua sits down for a conversation with U.S. Commerce Secretary Wilbur Ross following reports of Russia linked investments. Then, Michael McKee discusses NY Fed President William Dudley's recent retirement announcement. Prior to that, Jonathan Golub, Credit Suisse Securities' chief U.S. equity strategist, says the markets are perceiving Jay Powell as a continued Janet Yellen governance. Howard Gleckman, a senior fellow at the Tax Policy Center, says the Republican tax bill's proposed 20 percent corporate tax rate won't survive. Finally, Mohammed Alyahya, a nonresident fellow at the Rafik Hariri Center for the Middle East, says the issue of a Saudi corruption 'Band-Aid' is being torn off but perhaps may lead to uncertainty. 

As the 115th Congress weighs tax reform policy, Taxology takes a look back at the last time the United States actually enacted substantive tax reform. A conversation with Eugene Steuerle, Janice Mays, and Howard Gleckman reveals what was happening behind the scenes at the time and what lessons current lawmakers and White House officials can use going forward.

If you experience any technical difficulties with this video or would like to make an accessibility-related request, please send a message to digicomm@uchicago.edu. Equity and Choice in Health Care Access, a conference in celebration of the 50th anniversary of the Center for Health Administration Studies (CHAS) at the University of Chicago School of Social Service Administration, kicked off with a session that included two speakers and a respondent, entitled, “Long-Term Care Needs and Access to Care under the ACA.” The first speaker was Howard Gleckman, discussing the challenges of the long-term care model in the United States, potential solutions, and movement toward reform. Bio: http://howardgleckman.com/gleckman-bio.htm

If you experience any technical difficulties with this video or would like to make an accessibility-related request, please send a message to digicomm@uchicago.edu. Equity and Choice in Health Care Access, a conference in celebration of the 50th anniversary of the Center for Health Administration Studies (CHAS) at the University of Chicago School of Social Service Administration, kicked off with a session that included two speakers and a respondent, entitled, “Long-Term Care Needs and Access to Care under the ACA.” The first speaker was Howard Gleckman, discussing the challenges of the long-term care model in the United States, potential solutions, and movement toward reform. Bio: http://howardgleckman.com/gleckman-bio.htm